[Comparative Analysis of Family A DNA-Polymerases as a Searching Tool for Enzymes with New Properties].

Autor: Bulygin AA; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090 Russia.; Novosibirsk National Research State University, Novosibirsk, 630090 Russia., Kuznetsova AA; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090 Russia., Fedorva OS; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090 Russia., Kuznetsov NA; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090 Russia.; Novosibirsk National Research State University, Novosibirsk, 630090 Russia.; nikita.kuznetsov@niboch.nsc.ru.

Publikováno v: Molekuliarnaia biologiia [Mol Biol (Mosk)] 2023 Mar-Apr; Vol. 57 (2), pp. 185-196.

Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery.

Autor: Zakharova MY; Institute of Bioorganic Chemistry, Russian Academy of Sciences (RAS), Moscow, Russia.; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Kuznetsova AA; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch (SB) of RAS, Novosibirsk, Russia., Uvarova VI; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia., Fomina AD; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia., Kozlovskaya LI; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia., Kaliberda EN; Institute of Bioorganic Chemistry, Russian Academy of Sciences (RAS), Moscow, Russia., Kurbatskaia IN; Institute of Bioorganic Chemistry, Russian Academy of Sciences (RAS), Moscow, Russia., Smirnov IV; Institute of Bioorganic Chemistry, Russian Academy of Sciences (RAS), Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia., Bulygin AA; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch (SB) of RAS, Novosibirsk, Russia., Knorre VD; Institute of Bioorganic Chemistry, Russian Academy of Sciences (RAS), Moscow, Russia., Fedorova OS; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch (SB) of RAS, Novosibirsk, Russia., Varnek A; Laboratoire de Chémoinformatique, UMR 7140 CNRS, Université de Strasbourg, Strasbourg, France., Osolodkin DI; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia.; Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia., Ishmukhametov AA; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia., Egorov AM; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia., Gabibov AG; Institute of Bioorganic Chemistry, Russian Academy of Sciences (RAS), Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia.; Department of Biology and Biotechnology, Higher School of Economics, Moscow, Russia., Kuznetsov NA; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch (SB) of RAS, Novosibirsk, Russia.; Department of Natural Sciences, Novosibirsk State University, Novosibirsk, Russia.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2021 Dec 06; Vol. 12, pp. 773198. Date of Electronic Publication: 2021 Dec 06 (Print Publication: 2021).